This interactive allows users to track public opinion on a national health plan using all nationally representatives polls conducted since 2016, with further analysis of how favorability toward such a plan may differ based on political party identification and question wording.
- view as grid
- view as list
In an Axios column, Drew Altman explains that the elimination of the Affordable Care Act’s individual mandate penalty has had little impact on how the ACA’s insurance markets are working, showing that “the marketplaces continue to function, even when ‘severed’ from the mandate penalty,” and undercutting a central argument in the lawsuit seeking to strike down the entire law.
Medicare-for-all is popular with Democrats in battleground states, but not with swing voters. In this Axios column, Drew Altman discusses the implications of the KFF-Cook Political Report poll findings.
Poll: On Health Care, Democrats and Democratic-Leaning Independents Trust Sen. Sanders the Most, but Significantly More People Support a Public Option than Medicare-for-All
3 in 4 Americans Do Not Expect Congress to Take Action to Lower Drug Costs Before the 2020 Election Ahead of tonight’s Democratic presidential debate, Sen. Bernie Sanders is the candidate most trusted on health care by Democrats and Democratic-leaning independents, though the Medicare-for-all plan he has championed is significantly…
This analysis looks at how many of the remaining uninsured are eligible for premium subsidies that are large enough to cover the entire cost of a bronze plan, which is the minimum level of coverage available on the Marketplaces. It estimates 28% of uninsured individuals who could shop on the ACA Marketplace, or 4.7 million people nationwide, are eligible to purchase a bronze plan with $0 premiums after subsidies in 2020.
In Drew Altman’s Axios column, he analyzes new polling showing that rather than serving as backup to the states, the public wants the federal government to lead the nation’s coronavirus response.
This brief estimates the total amount that will be spent to reimburse hospitals for care for the uninsured with COVID-19, the disease caused by the coronavirus.
Medicare Beneficiaries Without Supplemental Coverage Are at Risk for Out-of-Pocket Costs Relating to COVID-19 Treatment
Most Medicare Advantage enrollees are in plans that have waived cost sharing for COVID-19 treatment, and many other beneficiaries in traditional Medicare have their cost sharing covered by supplemental insurance. This blog post discusses the 6 million Medicare beneficiaries without supplemental coverage who would face out-of-pocket costs if they require treatment for COVID-19.
Medicaid beneficiaries, particularly those with chronic conditions, will need access to medications even during social distancing and their ability to meet with providers to obtain refills may be hindered. States are updating policies to allow beneficiaries to access medications during this public health emergency.
As more coronavirus cases and deaths are confirmed in jails and prisons, states can utilize programs and other policy actions to mitigate the risk and spread of the disease within facilities and the broader communities in which they are located, according to a new issue brief from KFF. More than…